Terms: = Kidney tumors AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037
2074 results:
1. Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology.
Marvaso G; Jereczek-Fossa BA; Zaffaroni M; Vincini MG; Corrao G; Andratschke N; Balagamwala EH; Bedke J; Blanck O; Capitanio U; Correa RJM; De Meerleer G; Franzese C; Gaeta A; Gandini S; Garibaldi C; Gerszten PC; Gillessen S; Grubb WR; Guckenberger M; Hannan R; Jhaveri PM; Josipovic M; Kerkmeijer LGW; Lehrer EJ; Lindskog M; Louie AV; Nguyen QN; Ost P; Palma DA; Procopio G; Rossi M; Staehler M; Tree AC; Tsang YM; Van As N; Zaorsky NG; Zilli T; Pasquier D; Siva S
Lancet Oncol; 2024 May; 25(5):e193-e204. PubMed ID: 38697165
[TBL] [Abstract] [Full Text] [Related]
2. Impact of hyperuricemia and chronic kidney disease on the prevalence and mortality of cardiovascular disease in cancer survivors.
Chen Y; Chen Y; Lin W; Fu L; Liu H; Pu S; Chen H; Yi H; Xue Y
Cancer Med; 2024 May; 13(9):e7180. PubMed ID: 38686569
[TBL] [Abstract] [Full Text] [Related]
3. Patient's self-reported quality of life as a prognostic factor in metastatic renal cell carcinoma initially treated with TKI: nomogram proposal.
Lendínez-Cano G; Vilches-Arenas Á; Congregado-Ruíz B; Medina-López R
World J Urol; 2024 Apr; 42(1):267. PubMed ID: 38678165
[TBL] [Abstract] [Full Text] [Related]
4. Immunocompromised individuals are at increased risk of COVID-19 breakthrough infection, hospitalization, and death in the post-vaccination era: A systematic review.
Bytyci J; Ying Y; Lee LYW
Immun Inflamm Dis; 2024 Apr; 12(4):e1259. PubMed ID: 38661301
[TBL] [Abstract] [Full Text] [Related]
5. Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials.
Roller A; Davydov II; Schwalie PC; Serrano-Serrano ML; Heller A; Staedler N; Ferreira CS; Dietmann G; Klaman I; Valdeolivas A; Korski K; Cannarile MA
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38649280
[TBL] [Abstract] [Full Text] [Related]
6. Biomarker vs MRI-Enhanced Strategies for Prostate Cancer Screening: The STHLM3-MRI Randomized Clinical Trial.
Björnebo L; Discacciati A; Falagario U; Vigneswaran HT; Jäderling F; Grönberg H; Eklund M; Nordström T; Lantz A
JAMA Netw Open; 2024 Apr; 7(4):e247131. PubMed ID: 38648061
[TBL] [Abstract] [Full Text] [Related]
7. Challenges and technical aspects in the management of muscle invasive bladder cancer as retrograde radical cystectomy with ileal conduit.
Nusrat NB; Rehman AU; Zafar N; Muhammad S; Bajwa SI; Imtiaz S
J Pak Med Assoc; 2024 Mar; 74(3):513-518. PubMed ID: 38591289
[TBL] [Abstract] [Full Text] [Related]
8. Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Machiels JP; Tao Y; Licitra L; Burtness B; Tahara M; Rischin D; Alves G; Lima IPF; Hughes BGM; Pointreau Y; Aksoy S; Laban S; Greil R; Burian M; Hetnał M; Delord JP; Mesía R; Taberna M; Waldron JN; Simon C; Grégoire V; Harrington KJ; Swaby RF; Zhang Y; Gumuscu B; Bidadi B; Siu LL;
Lancet Oncol; 2024 May; 25(5):572-587. PubMed ID: 38561010
[TBL] [Abstract] [Full Text] [Related]
9. Cancer-specific mortality in non-metastatic T1a renal cell carcinoma treated with radiotherapy versus partial nephrectomy.
de Angelis M; Morra S; Scheipner L; Siech C; Jannello LMI; Baudo A; Goyal JA; Tian Z; Longo N; Ahyai S; de Cobelli O; Chun FKH; Saad F; Shariat SF; Carmignani L; Montorsi F; Briganti A; Karakiewicz PI
World J Urol; 2024 Mar; 42(1):193. PubMed ID: 38530480
[TBL] [Abstract] [Full Text] [Related]
10. Unusual Urothelial tumors and Refractory Uremia Due to Balkan Endemic Nephropathy: A Case Report.
Arabyan G; Hambartzhumian R; Lim A; Quizon M; Oberndorf J; Sanford MA
J Investig Med High Impact Case Rep; 2024; 12():23247096241238529. PubMed ID: 38494779
[TBL] [Abstract] [Full Text] [Related]
11. Robot-assisted single-port retroperitoneal partial nephrectomy with a novel purpose-built single-port robotic system with deformable surgical instruments.
Zhang C; Wang Z; Jing T; Wei Y; Guo F; Zhang Z; Xiao C; Wang Y; Xu H; Wu X; Tang S; Yang B; Wang S; Xu B; Zhu Q; Xia D; Wang L
World J Urol; 2024 Mar; 42(1):134. PubMed ID: 38478100
[TBL] [Abstract] [Full Text] [Related]
12. The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data.
Erdem S; Bertolo R; Campi R; Capitanio U; Amparore D; Anceschi U; Mir MC; Roussel E; Pavan N; Carbonara U; Kara O; Klatte T; Marchioni M; Pecoraro A; Muselaers S; Marandino L; Diana P; Borregales L; Palumbo C; Warren H; Wu Z; Calio A; Ciccarese C; Degirmenci E; Aydin R; Rebez G; Schips L; Simone G; Minervini A; Serni S; Ozcan F
Urol Oncol; 2024 May; 42(5):163.e1-163.e13. PubMed ID: 38443238
[TBL] [Abstract] [Full Text] [Related]
13. [Ultrasound-guided percutaneous thermal ablation assisted by artificial ascites and soft tissue edema in the treatment of special-region hepatic tumors].
Feng L; Wang Y; Niu LJ
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):155-160. PubMed ID: 38418190
[No Abstract] [Full Text] [Related]
14. Ultrasound image segmentation of renal tumors based on UNet++ with fusion of multiscale residuals and dual attention.
Qi H; Wang Z; Qi X; Shi Y; Xie T
Phys Med Biol; 2024 Mar; 69(7):. PubMed ID: 38412532
[No Abstract] [Full Text] [Related]
15. Survival assessment of nephron-sparing surgery or radical nephrectomy in children with unilateral Wilms tumor receiving adjuvant chemotherapy: a retrospective cross-sectional study.
Wu XW; Zhou PP; Dong Q
Eur Rev Med Pharmacol Sci; 2024 Feb; 28(3):1095-1102. PubMed ID: 38375715
[TBL] [Abstract] [Full Text] [Related]
16. External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations.
Maffezzoli M; Santoni M; Mazzaschi G; Rodella S; Lai E; Maruzzo M; Basso U; Bimbatti D; Iacovelli R; Anghelone A; Fiala O; Rebuzzi SE; Fornarini G; Lolli C; Massari F; Rosellini M; Mollica V; Nasso C; Acunzo A; Silini EM; Quaini F; De Filippo M; Brunelli M; Banna GL; Rescigno P; Signori A; Buti S
Clin Exp Metastasis; 2024 Apr; 41(2):117-129. PubMed ID: 38363410
[TBL] [Abstract] [Full Text] [Related]
17. Radiologic patterns of distant organ metastasis in advanced breast cancer patients: Prospective review of computed tomography images.
Jimah BB; Amoako E; Ofori EO; Akakpo PK; Aniakwo LA; Ulzen-Appiah K; Imbeah EG; Morna MT; Koggoh P; Akligoh H; Tackie R; Manu A; Paemka L; Sarkodie BD; Offei AK; Hutchful D; Ngoi J; Bediako Y; Rahman GA
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1988. PubMed ID: 38351553
[TBL] [Abstract] [Full Text] [Related]
18. kidney scoring surveillance: predictive machine learning models for clear cell renal cell carcinoma growth using MRI.
Yazdian Anari P; Zahergivar A; Gopal N; Chaurasia A; Lay N; Ball MW; Turkbey B; Turkbey E; Jones EC; Linehan WM; Malayeri AA
Abdom Radiol (NY); 2024 Apr; 49(4):1202-1209. PubMed ID: 38347265
[TBL] [Abstract] [Full Text] [Related]
19. Role of PSMA-targeted PET-CT in renal cell carcinoma: a systematic review and meta-analysis.
Singhal T; Singh P; Parida GK; Agrawal K
Ann Nucl Med; 2024 Mar; 38(3):176-187. PubMed ID: 38340144
[TBL] [Abstract] [Full Text] [Related]
20. Regional differences in upper tract urothelial carcinoma patients across the United States.
Morra S; Scheipner L; Baudo A; Jannello LMI; de Angelis M; Siech C; Goyal JA; Touma N; Tian Z; Saad F; Califano G; la Rocca R; Capece M; Shariat SF; Ahyai S; Carmignani L; de Cobelli O; Musi G; Briganti A; Chun FKH; Longo N; Karakiewicz PI
Urol Oncol; 2024 May; 42(5):162.e1-162.e10. PubMed ID: 38336499
[TBL] [Abstract] [Full Text] [Related]
[Next]
